QA: Allergan plc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001578845_2020_Allergan_plc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001578845, Allergan plc

  xvar xval
0 AssetsCurrent 11,126,700,000
1 IntangibleAssetsNetIncludingGoodwill 80,138,900,000
2 PropertyPlantAndEquipmentNet 1,926,500,000
3 remainder_Assets 1,507,000,000
4 LiabilitiesCurrent 11,070,700,000
5 LiabilitiesNoncurrent 1,247,000,000
6 remainder_Liabilities 24,185,000,000
7 CostOfGoodsAndServicesSold 2,541,265,522
8 SellingGeneralAndAdministrativeExpense 2,915,721,150
9 ResearchAndDevelopmentExpense 1,559,214,440
10 remainder_Expenses 13,552,507,851
11 remainder_Revenues 16,327,266,680
12 remainder_NetIncome -654,548,101
13 remainder_ComprehensiveNetIncome -304,937,125
  yvar yval
0 Assets 94,699,100,000
1 Liabilities 36,502,700,000
2 Expenses 20,568,708,963
3 Revenues 16,327,266,680
4 StockholdersEquity 58,196,400,000
5 NetIncome -4,895,990,384
6 ComprehensiveNetIncome -5,048,458,946
7 BaseVar 84,528,630,434
8 EconomicCapitalRatiobeforeLimitedLiability 1.86
9 EconomicCapitalRatio 2.93

Edgar->Model Mapping

Feature Distribution

Change over Time